Cargando…
Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients
The outbreak of novel coronavirus disease 2019 (COVID-19) has now become a global pandemic. Coagulopathy has been reported widely in critically ill COVID-19 patients and was related to high mortality. However, the comprehensive coagulation profiles have not been examined and the underlying mechanism...
Autores principales: | Zhang, Yan, Cao, Wei, Jiang, Wei, Xiao, Meng, Li, Yongzhe, Tang, Ning, Liu, Zhengyin, Yan, Xiaowei, Zhao, Yongqiang, Li, Taisheng, Zhu, Tienan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346854/ https://www.ncbi.nlm.nih.gov/pubmed/32648093 http://dx.doi.org/10.1007/s11239-020-02182-9 |
Ejemplares similares
-
Absorbing filter AN69 surface treatment in critically ill COVID-19 patients: a single-center experience
por: Chen, Gang, et al.
Publicado: (2021) -
Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19
por: Ma, Jie, et al.
Publicado: (2020) -
Myocardial Injury on Admission as a Risk in Critically Ill COVID-19 Patients: A Retrospective in-ICU Study
por: Qian, Hao, et al.
Publicado: (2021) -
Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19)
por: Gao, Peng, et al.
Publicado: (2021) -
Neurological Manifestations in Critically Ill Patients With COVID-19: A Retrospective Study
por: Fan, Siyuan, et al.
Publicado: (2020)